dockets: FDA-2005-P-0313

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

This data as json

id	agency_id	title	docket_type	last_modified	object_id
FDA-2005-P-0313	FDA	FDA to Refuse to Approve ANDA or Section 505(b)(2), for Inhalation Drug Products Containing A Combination of the Active Ingredients Albuterol Sulfate & Ipratropium Hydrochloirde Administered by Nebulization for the Treatment of Chronic Pulmonary Obstructive Disorder-CLOSED	Nonrulemaking	2021-09-01T01:01:24Z	0b000064804479c2

Links from other tables